{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-124348","form_type":"8-K","ticker":"PRAX","cik":"0001689548","company_name":"Praxis Precision Medicines, Inc.","filed_at":"2023-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.065419+00:00","generated_at":"2026-06-07T16:16:12.050136+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Praxis Precision Medicines enters $75M ATM equity offering with Jefferies LLC","bullets":["Up to $75M of common stock may be sold from time to time via Jefferies as sales agent.","Jefferies receives 3.0% commission on gross proceeds; company grants customary indemnification.","Sales will be made under existing effective shelf registration statement (S-3, Feb 2023).","Agreement can be terminated by either party upon 10 trading days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-124348","json":"https://secwatch.observer/filing/0001104659-23-124348.json","markdown":"https://secwatch.observer/filing/0001104659-23-124348.md","text":"https://secwatch.observer/filing/0001104659-23-124348.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689548/000110465923124348/0001104659-23-124348-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689548/000110465923124348/tm2332391d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T16:16:12.050136+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e5ac9893642586c4acc992b1dd623e159e8b69b4","claim":"Praxis Precision Medicines, Inc. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $75,000,000 (effective 2023-12-07).","evidence_excerpt":"On December 7, 2023, Praxis Precision Medicines, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”) to sell shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), with an aggregate offering price of up to $75,000,000, from time to time, through an “at the market” equity offering program under which Jefferies will act as sales agent.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465923124348/0001104659-23-124348-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Jefferies LLC"},{"label":"Value","value":"up to $75,000,000"},{"label":"Effective","value":"2023-12-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}